Environment
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
StateUtahEnacted
SB 66: Medical Cannabis Pharmacy License Amendments
Evan Vickers
SB 66 status: Enacted — Governor Signed (updated Mar 26, 2026).
Source
OpenStates
Confidence
Low
Analysis basis
OpenStates summary
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
59OUT OF 100
Score:59/100 civic fit
Risk:Moderate Risk
Impact:Moderate Impact 55/100
Constitutionality85%
Bipartisan70%
Public opinion65%
Bill summary
Here are a few ways to say this simply: * **"The Senate is currently updating the rules for medical marijuana stores."** * **"Senators are deciding on changes to how medical marijuana shops get their permits."** * **"New laws about medical marijuana pharmacies are being discussed in the Senate right now."**
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
Positive outlook
60%
Benefits
- Streamlined permit acquisition processes
- Increased market regulatory stability
- Standardized operating compliance requirements
Risks
- Potential for increased administrative compliance costs
- Administrative bottlenecks during implementation
- Barriers to entry for smaller pharmacy operators
Society
Positive outlook
60%
Benefits
- Greater consistency in patient access
- Professionalized dispensing and patient services
- Clearer expectations for pharmacy-patient interactions
Risks
- Potential temporary disruption to patient supply
- Geographic concentration risk if licensing limits apply
- Regulatory delays potentially affecting availability
Technology Industry
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Civic Accountability
Mixed / Neutral
55%
Benefits
- Formalization of administrative rulemaking processes
- Clearer legislative delegation of regulatory authority
- Improved oversight of pharmacy license distribution
Risks
- Potential for bureaucratic over-reach in rule implementation
- Reduced agency flexibility in policy adjustments
- Centralization of administrative authority
Public Health & Safety
Positive outlook
60%
Benefits
- Standardized quality and safety control measures
- Reliable access to monitored health treatments
- Enforced safety protocols for controlled substances
Risks
- Potential for supply chain gaps due to licensing changes
- Administrative hurdles that may delay patient access
- Regulatory inconsistency during the rule adoption phase
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Source
OpenStates
Official bill text or data from OpenStates.
Confidence
Low
Information is limited or incomplete.
Analysis basis
OpenStates summary
Source used for this bill's analysis.
Source note
Specific regulatory burden cannot be determined without the enacted text.
Analysis scope
Analysis based solely on a high-level legislative summary.
04
Where it stands
Official recordGovernor Signed
- IntroducedComplete
- CommitteeComplete
- Chamber votesComplete
- Final agreementComplete
- GovernorComplete
- EnactedComplete
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.